Cargando…

Prolonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer

• A case report of a 14 year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented. • Intraperitoneal IL-2 was given with little toxicity. • Immunotherapy may have the potential for durable remissions in ovarian cancer.

Detalles Bibliográficos
Autores principales:	Minor, David R., Moores, Samantha P., Chan, John K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633818/ https://www.ncbi.nlm.nih.gov/pubmed/29034306 http://dx.doi.org/10.1016/j.gore.2017.09.009

Ejemplares similares

Prolonged Survival of a Patient With Pelvic Recurrence of Ovarian Malignant Mixed Mullerian Tumor After Chemoradiotherapy
por: Homaei Shandiz, Fatemeh, et al.
Publicado: (2014)

Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data
por: Adambekov, Shalkar, et al.
Publicado: (2020)

Long-term durable responses after pembrolizumab immunotherapy for recurrent, resistant endometrial cancer
por: Chan, John K., et al.
Publicado: (2020)

Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy
por: Hue, Hyejeong, et al.
Publicado: (2019)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Profound sensorineural hearing loss after one cycle of intraperitoneal cisplatin in treatment of advanced ovarian cancer
por: McDonald, Megan E., et al.
Publicado: (2017)

Necrotizing fasciitis after placement of intraperitoneal catheter()
por: Carter, Jori S., et al.
Publicado: (2013)

Gastric Volvulus: A Delayed Surgical Complication After Debulking and Hyperthermic Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
por: Ghattas, Souad, et al.
Publicado: (2023)

Extensive cutaneous metastases of ovarian cancer after prolonged response to liposomal doxorubicin()()()
por: Craig, Christine D., et al.
Publicado: (2013)

The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer
por: Glennon, Kate, et al.
Publicado: (2021)

Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer with Incidental Bochdalek Hernia and Postoperative Bilateral Thalamic Infarct: A Case Report
por: Kahramanoglu, Ilker, et al.
Publicado: (2017)

Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.
por: Malik, S. T., et al.
Publicado: (1992)

Urachal Carcinoma with Peritoneal Dissemination Treated with Chemotherapy and Surgical Resection Leading to Prolonged Survival with No Recurrence
por: Yasui, Masato, et al.
Publicado: (2018)

Prolonged survival after laser interstitial thermal therapy in glioblastoma
por: Khan, A. Basit, et al.
Publicado: (2021)

Intraperitoneal cisplatin and doxorubicin as maintenance chemotherapy for unresectable ovarian cancer: a case report
por: Tempfer, Clemens B., et al.
Publicado: (2017)

Incidental Finding of Intraperitoneal Tuberculosis in a Patient Presenting with a Large Ovarian Mass
por: Green, Ayla, et al.
Publicado: (2018)

Case of pseudo-Meigs' syndrome caused by gastric cancer-related metastatic ovarian tumor with prolonged survival
por: Okamoto, Masaru, et al.
Publicado: (2016)

Gastrointestinal-type chemotherapy prolongs survival in an atypical primary ovarian mucinous carcinoma: A case report
por: Wang, Qi, et al.
Publicado: (2021)

Prolonged and Recurrent Intrahepatic Cholestasis of Pregnancy
por: Kaviani, Rojin, et al.
Publicado: (2023)

Survival after severe amitriptyline poisoning with prolonged ventricular tachycardia and cardiac arrest
por: Abeyaratne, Dayakshi D. K., et al.
Publicado: (2016)

Elevated tumor mutational burden and prolonged clinical response to anti-PD-L1 antibody in platinum-resistant recurrent ovarian cancer
por: Morse, Christopher B., et al.
Publicado: (2017)

Prolonged survival in a patient with isolated skull recurrence of cervical carcinoma — Case report and review of the literature
por: Zilberlicht, Ariel, et al.
Publicado: (2014)

Aggressive multimodal therapy may prolong disease-free survival in recurrent primary retroperitoneal embryonal carcinoma
por: Straka, Martin, et al.
Publicado: (2015)

Hepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrence
por: Pazgan-Simon, Monika, et al.
Publicado: (2018)

Tumor Recurrence in a Glioblastoma Patient after Discontinuation of Prolonged Temozolomide Treatment
por: Tseng, Wei-Lung, et al.
Publicado: (2017)

Delivery Induced Intraperitoneal Rupture of a Cystic Ovarian Teratoma and Associated Chronic Chemical Peritonitis
por: Nader, Reine, et al.
Publicado: (2014)

A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer
por: Burke, Morgan, et al.
Publicado: (2018)

Intraperitoneal Rupture of Ovarian Cysts
por: Das, Kedarnath
Publicado: (1901)

Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)

Successful treatment of peritoneal recurrence after gastric cancer surgery with intravenous and intraperitoneal paclitaxel combined with S-1 chemotherapy: a case report
por: Miyatani, Kozo, et al.
Publicado: (2020)

Delayed diagnosis of intraperitoneal bladder perforation after blunt trauma
por: Wang, Lu, et al.
Publicado: (2019)

Drain site enterocutaneous fistula after hyperthermic intraperitoneal chemotherapy
por: Kumar, Navin, et al.
Publicado: (2020)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)

Prolonged survival after splenectomy in Wiskott-Aldrich syndrome: a case report
por: Syrigos, Kostas N, et al.
Publicado: (2011)

Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel
por: Rauwerdink, Paulien, et al.
Publicado: (2022)

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
por: Chan, Daniel L, et al.
Publicado: (2012)

Multiparametric MRI assessment of response to convection-enhanced intratumoral delivery of MDNA55, an interleukin-4 receptor targeted immunotherapy, for recurrent glioblastoma
por: Mohan, Suyash, et al.
Publicado: (2021)

Survival outcomes and toxicity of intraoperative intraperitoneal chemotherapy in advanced epithelial ovarian cancer
por: Yoon, Ji-Young, et al.
Publicado: (2014)

Intraperitoneal recurrence of renal haemangiopericytoma
por: El M’rabet, Fatima Zahra, et al.
Publicado: (2017)

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
por: Acs, Miklos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k6k927eoi418uaqd7scec4o9p3